Results 31 to 40 of about 3,374,023 (302)

ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas

Scientific Reports, 2021
In type 1 endometrial cancer, unopposed estrogen stimulation is thought to lead to endometrial hyperplasia which precedes malignant progression. Recent data from our group and others suggest that ALDH activity mediates stemness in endometrial cancer, but
Vei Mah, Yahya Elshimali, Alison Chu, Neda A. Moatamed, Jamar P. Uzzell, Jessica Tsui, Stephen Schettler, Hania Shakeri, Madhuri Wadehra   +8 more
doaj   +1 more source

Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis [PDF]

, 2010
Background: Body mass index (BMI) is a risk factor for endometrial cancer. We quantified the risk and investigated whether the association differed by use of hormone replacement therapy (HRT), menopausal status, and histologic type. Methods: We searched
Crosbie, Emma J, Crosbie, Emma J.; id_orcid, Matthias Egger, Egger, Matthias, Zwahlen, Marcel, Kitchener, Henry C, Andrew G. Renehan, Kitchener, Henry C., Marcel Zwahlen, Renehan, Andrew G., Henry C. Kitchener, Emma J. Crosbie, Renehan, Andrew G, Zwahlen, M, Egger, M   +14 more
core   +1 more source

Endometrial Hyperplasia and Endometrial Carcinoma [PDF]

, 2020
Endometrial hyperplasia and endometrial carcinoma are rare in young women, but the incidence is continually increasing in developed countries due to obesity and metabolic diseases.
Wimberger, Pauline, Maren Goeckenjan, von Wolff, Michael, Michael von Wolff, Goeckenjan, Maren, Pauline Wimberger   +5 more
core   +1 more source

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts [PDF]

, 2013
Lynch syndrome (LS) is characterised by the development of colorectal cancer, endometrial cancer and various other cancers, and is caused by a mutation in one of the mismatch repair genes: MLH1, MSH2, MSH6 or PMS2.
Capella, G., Moeslein, Gabriela, Moslein, G., Vasen, Hans F. A., Sijmons RH, Engel, C., Leon, M., Møller P, Gopie, JP, Bertario, Lucio, Alonso A, Genuardi, M., Burn J, Engel, Christoph, PONZ DE LEON, Maurizio, Alonso, A, Wijnen, J.T., Burn, John, Lindblom, Annika, Heinimann, Karl, Tejpar, Sabine, Vasen HF, Bertario L, Leon, M.P. de, Thomas HJ, Maurizio Genuardi., Gopie JP, Myrhoj, T., Bernstein I, Hes, Frederik J., Stormorken, Astrid, Myrhoj, Torben, Aktan-Collan, Katja, Wijnen JT, Alonso, A., Tejpar, S., Nagengast, Fokko M., Aretz, S., Vasen, H.F., Myrhoj T, Stormorken A, Moller, P., Engel C, Järvinen HJ, Sampson, Julian R., Lalloo, F., Capella, G, Bernstein, I., Hodgson SV, Lindblom A, Bertario, L, Jaervinen, Heikki Juhani, Gopie, Jessica P., Karagiannis, John A., Burn, J, Karagiannis JA, Frayling, I.M., Sijmons, Rolf H., Sampson JR, Rahner, N., Blanco, I, Aktan Collan K, Hes FJ, Aktan-Collan, K, Blanco, I., Genuardi, Maurizio, Aretz, Stefan, Blanco, Ignacio, Nagengast, F.M., Thomas, Huw J. W., Lindblom, A., Gopie, J.P., Bertario, L., Moller, Pal, Thomas, H.J.W., Lalloo, Fiona, Rahner N, Renkonen-Sinisalo, Laura, Wijnen, Juul T., Alonso, Angel, Sampson, Julian Roy, Bernstein, Inge, Capella, Gabriel, Mallorca Grp, Jarvinen, H.J., Aretz S, Mallorca group, Vasen, H.F.A., Parc Y, Karagiannis, J.A., Bernstein, I, Hodgson, Shirley V., Rahner, Nils, et al., Parc, Y., Sampson, J.R., Aretz, S, Thomas, H.J., Frayling, Ian M., Capella G, Nagengast FM, Colas, C., Renkonen-Sinisalo, L., Tejpar S, Hes, F.J., Renkonen Sinisalo L, Frayling IM, Mecklin, Jukka-Pekka, Möslein G., de Leon, Maurizio Ponz, Lalloo F, Blanco I, Hodgson, S.V., Heinimann, K., Mecklin, J.P., Colas, Chrystelle, Frayling, Ian Martin, Parc, Yann, Heinimann K, Burn, J., Sijmons, R.H., Stormorken, A., Genuardi M, Colas C, Mecklin JP, Aktan-Collan, K., Vasen, HFA, Sampson, JR, Renkonen-Sinisalo, L, Genuardi, M, Heinimann, K, Tejpar, S, Rahner, N, Lindblom, A, Nagengast, FM, Hodgson, SV, Karagiannis, JA, Mecklin, JP, Engel, C, Ponz de Leon, M, Møller, P, Vasen, HF, Stormorken, A, Sijmons, RH, Myrhoj, T, Hes, FJ, Järvinen, HJ, Wijnen, JT, Frayling, IM, Parc, Y, Möslein, G, Lalloo, F, Colas, C, Thomas, HJ   +153 more
core   +1 more source

FIGO staging of endometrial cancer: 2023 [PDF]

, 2023
INTRODUCTION: Many advances in the understanding of the pathologic and molecular features of endometrial cancer have occurred since the FIGO staging was last updated in 2009.
Christina Fotopoulou, Carien Creutzberg, Creutzberg, Carien, Matias-Guiu, Xavier, 1958-, Xavier Matias-Guiu, FIGO, Womens Canc Comm, Kehoe, Sean, Mutch, David, David Gaffney, Berek, Jonathan S., Matias-Guiu, Xavier, Concin, Nicole, Kristina Lindemann, Jonathan S. Berek, Endometrial, Canc Staging Subcomm, Nicole Concin, Lindemann, Kristina, Fotopoulou, Christina, Sean Kehoe, Berek, Jonathan S, David Mutch, Gaffney, David, Endometrial Cancer Staging Subcommittee of the Figo Women's Cancer Committee   +22 more
core   +1 more source

Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial–mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKT

Animal Cells and Systems, 2021
Endometrial cancer is the most common gynecological cancer in the developed countries. Type II transmembrane serine proteases 4 (TMPRSS4) is a newly discovered transmembrane protein, which may be related to the invasion, metastasis of the tumor and the ...
Huan Xiao, Zhian Zhang, Dan Peng, Chunqing Wei, Benling Ma   +4 more
doaj   +1 more source

Prognostic value of angiogenic markers of endometrial cancer (literature review)

Сибирский онкологический журнал, 2022
Endometrial cancer is the most common cancer of the female reproductive organs. The purpose of the study was to summarize the available data on the role of angiogenic markers in the development, progression and prognosis of endometrial cancer.
N. S. Zolotukhina, L. F. Gulyaeva
doaj   +1 more source

Does Preoperative Diagnosis of Endometrial Hyperplasia Necessitate Intraoperative Frozen Section Consultation?

Balkan Medical Journal, 2016
Background: In women with endometrial hyperplasia, there is a risk for co-existent endometrial cancer when patients are subjected to immediate surgical treatment.
Gokhan Boyraz, Derman Başaran, Mehmet C. Salman, Nejat Özgül, Kunter Yüce   +4 more
doaj   +1 more source

Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia [PDF]

Journal of Clinical and Diagnostic Research, 2015
Introduction: Endometrial hyperplasia has been associated with the presence of concomitant endometrial carcinoma. In this study, patients who were diagnosed with endometrial hyperplasia and had hysterectomy, determination of the incidence of ...
Pinar Kadirogullari, Cemal Resat Atalay, Ozhan Ozdemir, Mustafa Erkan Sari   +3 more
doaj   +1 more source

Risk Factors for Endometrial Lesions Detected by Hysteroscopy in Breast Cancer Patients Taking Tamoxifen [PDF]

Zhongguo quanke yixue, 2023
Background Breast cancer has become the most common malignant tumor threatening the health of Chinese women in recent years. The use of tamoxifen (TAM) has successfully reduced the recurrence and progression of estrogen receptor-positive breast cancer ...
LI Yujing, JIN Yichao, CHEN Xing, JI Mengying, DAI Huihua
doaj   +1 more source